JURÁŇ, Vilém, Václav VYBÍHAL, Marek SOVA, Martin SMRČKA, Tomáš KAZDA, Martin PISKÁČEK and Andrea KNIGHT. Harnessing the EphA2 blockade in glioblastoma. In 4th congress on the Eph-ephrin system, Parma, Italy, May 16-17, 2024. 2024.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Harnessing the EphA2 blockade in glioblastoma
Authors JURÁŇ, Vilém (203 Czech Republic, belonging to the institution), Václav VYBÍHAL (203 Czech Republic, belonging to the institution), Marek SOVA (203 Czech Republic, belonging to the institution), Martin SMRČKA (203 Czech Republic, belonging to the institution), Tomáš KAZDA (203 Czech Republic, belonging to the institution), Martin PISKÁČEK (203 Czech Republic, belonging to the institution) and Andrea KNIGHT (203 Czech Republic, belonging to the institution).
Edition 4th congress on the Eph-ephrin system, Parma, Italy, May 16-17, 2024, 2024.
Other information
Original language English
Type of outcome Requested lectures
Field of Study 30212 Surgery
Country of publisher Italy
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Keywords in English glioblastoma; EphA2 blockade
Tags International impact
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 20/8/2024 08:23.
Abstract
Harnessing the EphA2 blockade in glioblastoma - conference abstract.
Links
NV19-05-00410, research and development projectName: Úloha cytotoxických gamma-delta T buněk na terapeutické rezistenci a recidivě Glioblastoma Multiforme
Investor: Ministry of Health of the CR
PrintDisplayed: 20/8/2024 19:02